The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): 11m
Expected first date of trading: 15/07/2014
Market: AIM
Location of address at which admission document will be available: Copies of the Admission Document (which will contain full details about the Company and the admission of its securities) will be available on the Company's website (www.ergomedgroup.com) and at the offices of the Company, 26-28 Frederick Sanger Road, Surrey Research Park, Guildford, Surrey GU2 7YD during normal business hours on any weekday (excluding Saturdays, Sundays and any public of bank holidays) from date of publication of the Admission Document until the date of Admission.
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Oriel Securities Limited
Nominated Broker (AIM Companies): Oriel Securities Limited
Financial PR Advisors: -

Company details
Name Role
Rolf Stahel Non-Executive Chairman
Miroslav Reljanovic Chief Executive Officer
Neil Clark Chief Financial Officer
Peter George Non-Executive Director
Christopher Collins Non-Executive Director

Facts and Figures
Fiscal year end: 31 December
Incorporated in: England and Wales
Website URL: www.ergomedgroup.com
space
Description of business:
Ergomed Plc is a UK-based company, dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs. Ergomed operates in over 40 countries engaging more than 200 people across five continents. Ergomed has two complementary businesses: (1) The Services Business - a well established, clinical research business providing services to the p...

Person(s) interested:
Shares Held pre Admission % Shares Held pre Admission Shares Held on Admission % interest on Admission Miroslav Reljanovic 20,000,000 100% 21,190,257 73.7% Octopus Investments - - 2,718,750 9.5%


Ergomed Plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds